BioCentury | Feb 13, 2012
Finance

Ventech reinvention

Ventech reinvention Ventech's life science specialists have landed at INSERM after the French VC decided to focus solely on IT. The life sciences team - General Partner Mounia Chaoui and Principal Laurent Assaraf - have joined INSERM...
BC Week In Review | Jan 10, 2011
Company News

Graftys board of directors update

Graftys S.A. , Aix-en-Provence, France   Business: Musculoskeletal, Computational chemistry/biology   Appointed: Laurent Assaraf, principal at Ventech  ...
BC Week In Review | Jan 10, 2011
Financial News

Graftys completes venture financing

Graftys S.A. , Aix-En-Provence, France   Business: Musculoskeletal, Computational chemistry/biology   Date completed: 1/5/11   Type: Venture financing   Raised: €4 million ($5.3 million)   Investors: Ventech; Octalfa S.A.S.; Viveris Management; Oreo Finances Corp.  ...
Items per page:
1 - 3 of 3
BioCentury | Feb 13, 2012
Finance

Ventech reinvention

Ventech reinvention Ventech's life science specialists have landed at INSERM after the French VC decided to focus solely on IT. The life sciences team - General Partner Mounia Chaoui and Principal Laurent Assaraf - have joined INSERM...
BC Week In Review | Jan 10, 2011
Company News

Graftys board of directors update

Graftys S.A. , Aix-en-Provence, France   Business: Musculoskeletal, Computational chemistry/biology   Appointed: Laurent Assaraf, principal at Ventech  ...
BC Week In Review | Jan 10, 2011
Financial News

Graftys completes venture financing

Graftys S.A. , Aix-En-Provence, France   Business: Musculoskeletal, Computational chemistry/biology   Date completed: 1/5/11   Type: Venture financing   Raised: €4 million ($5.3 million)   Investors: Ventech; Octalfa S.A.S.; Viveris Management; Oreo Finances Corp.  ...
Items per page:
1 - 3 of 3